Dr. Charles Olomofe, visiting assistant professor of Public Health, had an abstract accepted for poster presentation at the annual conference of the Society for Epidemiologic Research (SER), in Boston ...

Students gave 69 poster presentations and 24 oral presentations at the University of North Georgia's (UNG) 30th Annual ...

today announced two abstracts accepted for poster presentations at the upcoming European Lung Cancer Congress (ELCC) 2025 Scientific Committee and Mayo Clinic Multidisciplinary Head and Neck ...

2025 at 4:00 pm during Oral Poster Presentation: Research 3 at NKF SCM25, Dr. Wolfgang Winkelmayer will present a poster titled “Vadadustat for Treatment of Anemia in Older vs Younger Patients ...

today announced the company will present three posters at the American Thoracic Society (ATS) 2025 International Conference, taking place May 18-21, 2025, in San Francisco. Two posters will highlight ...

In this episode of Ask Us Anything, Dane Austin joins the show to answer a question from a fellow designer who is looking to bring a higher level of refinement to her client presentations.

Presentations will feature potential best-in-class pan-RAS molecular glue ERAS-0015 and pan-KRAS inhibitor ERAS-4001 Erasca will also present potential first-in-class examples of direct SMP ...

Erasca will also present potential first-in-class examples of direct SMP complex inhibitors, representing a new approach to block the RAS/MAPK pathway SAN DIEGO, March 25, 2025 (GLOBE NEWSWIRE ...

Gain Therapeutics' lead drug candidate, GT-02287, is in clinical development for the treatment of Parkinson's disease (PD) with or without a GBA1 mutation. The orally administered, brain-penetrant ...

We are now accepting proposals for presentations at the 2025 Annual Conference which will be held in person at RUSI’s headquarters in London on 16 September. The UK PONI Annual Conference is the ...

today announced upcoming poster presentations including one for CM24 in the treatment of pancreatic cancer, and two for NT219 in the treatment of colorectal and head and neck cancers, at the 2025 ...